Related Experiment Video
Updated: May 10, 2025

Three-Dimensional 3D Tumor Spheroid Invasion Assay
Published on: May 1, 2015
The Role of Cavin3 in the Development of Malignant Tumors
Lei Qian1,2, Ziqian Zhang3, Hongning Cai2
1Hubei University of Medicine, Shiyan, Hubei Province, 442000, People's Republic of China.
Abstract:
Cavin3, also known as PRKCDBP or SRBC, is an important member of the Cavin family. It plays a crucial role in the formation and functional regulation of caveolae while also acting as a tumor suppressor in the occurrence and development of most malignant tumors, primarily regulated by promoter region methylation. This paper systematically reviews the research progress of Cavin3 in breast cancer, lung cancer, gastric cancer, colorectal cancer and gynecological tumors, focusing on the role of Cavin3 in tumor prognosis and its possible regulatory mechanism. Current studies have shown that in breast cancer and lung cancer, Cavin3 can exert anti-tumor effects by inhibiting the PI3K/AKT signaling pathway and participating in DNA damage repair. In gastric cancer, it mainly activates downstream pathways by stabilizing p53, inducing cell cycle arrest and apoptosis. However, the specific role of Cavin3 in other tumor types and its broader regulatory mechanism have not yet been fully clarified and further in-depth research is needed. Future research on Cavin3 may provide new insights and effective strategies for precision diagnosis and treatment of malignant tumors.
Insights
Cavin3 acts as a tumor suppressor in various cancers by regulating caveolae formation. It shows anti-tumor effects in breast and lung cancers via the PI3K/AKT pathway and DNA repair, and in gastric cancer by stabilizing p53.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Cavin3 (PRKCDBP/SRBC) is a key regulator of caveolae formation and function.
- It acts as a tumor suppressor in many malignant tumors, often regulated by promoter methylation.
Purpose of the Study:
- To systematically review Cavin3's role in breast, lung, gastric, colorectal, and gynecological cancers.
- To focus on Cavin3's impact on tumor prognosis and its regulatory mechanisms.
Main Methods:
- Systematic literature review of studies on Cavin3 in various cancer types.
- Analysis of Cavin3's involvement in signaling pathways and cellular processes.
Main Results:
- Cavin3 inhibits the PI3K/AKT pathway and aids DNA repair in breast and lung cancers.
- In gastric cancer, Cavin3 stabilizes p53, inducing cell cycle arrest and apoptosis.
- Cavin3's precise role and mechanisms in other cancers require further investigation.
Conclusions:
- Cavin3 exhibits significant anti-tumor activity across multiple cancer types.
- Understanding Cavin3's broader mechanisms could lead to novel precision oncology strategies.
- Further research is essential to fully elucidate Cavin3's therapeutic potential.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Cell Migration through Invadopodia
Induced Pluripotent Stem Cells
Somatic...

